Dan Liljenquist is the lead architect and Board Chair of Civica Rx, a new nonprofit generic drug company established to reduce chronic generic drug shortages and price gouging, which have negatively impacted patient care for over a decade. Dan's commentary on generic drug market issues was published in the New England Journal of Medicine (Addressing Generic Drug Market Failures--The Case for Establishing a Nonprofit Manufacturer) and informed Civica Rx's mission to ensure that essential generic medications are available and affordable to everyone. Dan is Senior Vice President and Chief Strategy Officer for Intermountain Healthcare, where he also oversees Intermountain's Enterprise Initiative and Market Intelligence & Planning Offices. Prior to joining Intermountain, Dan served in the Utah State Senate and was nationally recognized for his work on Medicaid and public-sector pension reforms. He is a former strategy consultant with Bain & Company, Inc. Dan received his JD from The University of Chicago Law School and his BA in Economics from Brigham Young University. Dan and his wife, Brooke, are the parents of six children and reside in Bountiful, Utah.